IMGN
ImmunoGen Inc
Price:  
31.23 
USD
Volume:  
49,500,890.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMGN WACC - Weighted Average Cost of Capital

The WACC of ImmunoGen Inc (IMGN) is 8.0%.

The Cost of Equity of ImmunoGen Inc (IMGN) is 8.05%.
The Cost of Debt of ImmunoGen Inc (IMGN) is 4.25%.

Range Selected
Cost of equity 7.10% - 9.00% 8.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 4.50% 4.25%
WACC 7.1% - 9.0% 8.0%
WACC

IMGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.69 0.74
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 4.00% 4.50%
After-tax WACC 7.1% 9.0%
Selected WACC 8.0%